Financial Snapshot

Revenue
$786.5M
TTM
Gross Margin
17.65%
TTM
Net Earnings
-$15.96M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
120.71%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$290.7M
Q3 2024
Cash
Q3 2024
P/E
-40.73
Nov 29, 2024 EST
Free Cash Flow
-$18.97M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2024 2023 2022 2021 2020 2019
Revenue $763.9M $688.1M $698.6M $637.8M $567.2M $465.6M
YoY Change 11.01% -1.51% 9.54% 12.45% 21.82%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2024 2023 2022 2021 2020 2019
Revenue $763.9M $688.1M $698.6M $637.8M $567.2M $465.6M
Cost Of Revenue $631.8M $586.8M $563.3M $463.7M $425.9M $355.0M
Gross Profit $132.1M $101.3M $135.4M $174.1M $141.3M $110.6M
Gross Profit Margin 17.29% 14.72% 19.38% 27.29% 24.91% 23.75%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019
Selling, General & Admin $136.3M $135.3M $125.9M $154.6M $77.48M $64.70M
YoY Change 0.76% 7.48% -18.58% 99.49% 19.76%
% of Gross Profit 103.2% 133.54% 92.97% 88.79% 54.84% 58.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $18.95M $15.42M $13.92M $12.29M $11.29M $9.000M
YoY Change 22.9% 10.74% 13.26% 8.88% 25.46%
% of Gross Profit 14.35% 15.22% 10.29% 7.06% 7.99% 8.14%
Operating Expenses $136.3M $135.3M $125.9M $154.6M $77.48M $69.90M
YoY Change 0.76% 7.48% -18.58% 99.49% 10.85%
Operating Profit -$23.18M -$49.40M -$4.406M -$12.34M $50.93M $40.70M
YoY Change -53.07% 1021.08% -64.29% -124.22% 25.14%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019
Interest Expense -$4.023M -$1.522M $2.526M $16.79M $14.62M -$9.600M
YoY Change 164.32% -160.25% -84.95% 14.83% -252.28%
% of Operating Profit 28.7% -23.59%
Other Income/Expense, Net $1.361M -$1.398M -$2.831M -$22.63M -$15.30M -$1.500M
YoY Change -197.35% -50.62% -87.49% 47.92% 920.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019
Pretax Income -$21.82M -$50.79M -$7.237M -$34.97M $35.60M $25.40M
YoY Change -57.04% 601.85% -79.3% -198.23% 40.16%
Income Tax $1.402M -$7.241M $723.0K $9.771M $9.868M $6.300M
% Of Pretax Income 27.72% 24.8%
Net Earnings -$21.34M -$40.67M -$6.521M -$43.99M $26.28M $19.60M
YoY Change -47.54% 523.72% -85.17% -267.39% 34.07%
Net Earnings / Revenue -2.79% -5.91% -0.93% -6.9% 4.63% 4.21%
Basic Earnings Per Share -$0.16 -$0.30 -$0.05 -$0.36 $0.20
Diluted Earnings Per Share -$0.16 -$0.30 -$0.05 -$0.36 $0.19 $147.1K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019
Cash & Short-Term Investments $102.8M $173.5M $184.4M $201.5M $112.9M $59.70M
YoY Change -40.75% -5.95% -8.46% 78.45% 89.11%
Cash & Equivalents $56.95M $127.2M $184.4M $201.5M $112.9M $59.70M
Short-Term Investments $45.83M $46.21M
Other Short-Term Assets $18.93M $17.16M $13.86M $11.48M $6.000M $4.700M
YoY Change 10.33% 23.83% 20.69% 91.38% 27.66%
Inventory
Prepaid Expenses
Receivables $48.11M $24.34M $35.91M $32.58M $46.30M $51.30M
Other Receivables $3.324M $262.0K $6.761M $5.401M $1.800M $3.700M
Total Short-Term Assets $173.1M $215.2M $241.0M $250.9M $166.9M $119.5M
YoY Change -19.55% -10.68% -3.98% 50.35% 39.67%
Property, Plant & Equipment $221.4M $213.4M $176.3M $142.7M $102.5M $101.2M
YoY Change 3.77% 21.07% 23.5% 39.23% 1.28%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.645M $5.493M $5.493M $3.493M $15.90M $15.40M
YoY Change -51.85% 0.0% 57.26% -78.03% 3.25%
Other Assets $5.949M $3.823M $2.812M $3.877M $3.000M $4.100M
YoY Change 55.61% 35.95% -27.47% 29.23% -26.83%
Total Long-Term Assets $374.5M $352.1M $314.6M $280.8M $242.7M $243.7M
YoY Change 6.36% 11.91% 12.04% 15.71% -0.41%
Total Assets $547.7M $567.4M $555.6M $531.8M $409.6M $363.2M
YoY Change
Accounts Payable $55.46M $54.94M $50.56M $32.36M $28.90M $30.40M
YoY Change 0.95% 8.65% 56.24% 11.98% -4.93%
Accrued Expenses $4.145M $3.530M
YoY Change 17.42%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $8.394M $8.517M $7.161M $5.869M $3.400M $3.600M
YoY Change -1.44% 18.94% 22.01% 72.62% -5.56%
Total Short-Term Liabilities $138.6M $148.5M $105.3M $78.57M $76.60M $83.50M
YoY Change -6.64% 40.97% 34.04% 2.57% -8.26%
Long-Term Debt $74.22M $77.96M $77.65M $76.76M $214.5M $191.1M
YoY Change -4.79% 0.4% 1.15% -64.21% 12.24%
Other Long-Term Liabilities $27.57M $19.91M $1.134M $2.758M $1.400M $1.100M
YoY Change 38.46% 1656.08% -58.88% 97.0% 27.27%
Total Long-Term Liabilities $101.8M $97.87M $78.78M $79.52M $215.9M $192.2M
YoY Change 4.01% 24.23% -0.93% -63.17% 12.33%
Total Liabilities $278.4M $271.1M $223.2M $196.6M $308.6M $289.0M
YoY Change 2.71% 21.42% 13.54% -36.29% 6.78%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2024 2023 2022 2021 2020 2019
Basic Shares Outstanding 135.9M shares 135.6M shares 135.5M 123.6M 132.6M
Diluted Shares Outstanding 135.9M shares 135.6M shares 135.5M 123.6M 135.2M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $650.19 Million

About InnovAge Holding Corp.

InnovAge Holding Corp. engages in the provision of a healthcare delivery platform. The company is headquartered in Denver, Colorado and currently employs 2,350 full-time employees. The company went IPO on 2021-03-04. The firm is focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. The firm's programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its Program of All-Inclusive Care for the Elderly (PACE) program, it fulfills a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center and third-party medical appointments; and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan.

Industry: Services-Health Services Peers: Accolade, Inc. CareMax, Inc. CASTLE BIOSCIENCES INC CROSS COUNTRY HEALTHCARE INC CVS HEALTH Corp DocGo Inc. Enhabit, Inc. Invitae Corp NATIONAL RESEARCH CORP RadNet, Inc.